Study to Assess Efficacy and Safety of VIT-2763 (Vamifeport) in Subjects With Sickle Cell Disease
Clinical trial NCT04817670 · COMPLETED
Trial details
- NCT number
- NCT04817670
- Sponsor
- Vifor (International) Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-18
- Primary completion
- 2024-03-07
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.